Page 110 - 202004
P. 110

·循证药学·

        鼻内给予右美托咪定对比口服水合氯醛用于儿童程序化镇静有

        效性和安全性的Meta分析                            Δ


               *
        刘克锋 ,杨勇杰,张晓坚,康 建(郑州大学第一附属医院药学部,郑州 450052)
                                      #
        中图分类号 R720.5          文献标志码 A          文章编号 1001-0408(2020)04-0484-06
        DOI   10.6039/j.issn.1001-0408.2020.04.18

        摘   要   目的:系统评价鼻内给予右美托咪定对比口服水合氯醛用于儿童程序化镇静的有效性和安全性。方法:计算机检索Co-
        chrane图书馆、PubMed、Embase、中国生物医学文献数据库、中国知网数据库和万方数据库,收集鼻内给予右美托咪定(试验组)对
        比口服水合氯醛(对照组)用于儿童程序化镇静的随机对照试验(RCT)。筛选文献、提取资料后采用Cochrane 5.1.0偏倚风险评估
        工具对纳入文献质量进行评价,采用Rev Man 5.3软件进行Meta分析。结果:共纳入8项RCT,共计1 413例患儿。Meta分析结果
        显示,试验组患儿镇静成功率[RR=1.13,95%CI(1.02,1.25),P=0.02]、镇静起效时间[MD=-1.07,95%CI(-1.82,-0.31),P=
        0.006]、镇静持续时间[MD=-8.25,95%CI(-14.02,-2.47),P=0.005]、苏醒时间[MD=-9.63,95%CI(-15.40,-3.86),P=
        0.001]、恶心呕吐发生率[RR=0.05,95%CI(0.02,0.14),P<0.000 01]均显著优于对照组;两组患儿血氧饱和度<95%发生率[RR=
        0.60,95%CI(0.24,1.54),P=0.29]、低血压发生率[RR=1.18,95%CI(0.51,2.74),P=0.71]、心动过缓发生率[RR=1.33,95%CI
        (0.18,9.88),P=0.78]比较,差异均无统计学意义。结论:鼻内给予右美托咪定相较于口服水合氯醛用于儿童程序化镇静的效果
        更优,且安全性较好。
        关键词 右美托咪定;鼻内给药;水合氯醛;口服;儿童;程序化镇静;有效性;安全性;Meta分析

        Meta-analysis of Efficacy and Safety of Intranasal Administration of Dexmedetomidine versus Oral Admini-
        stration of Chloral Hydrate for Programmed Sedation in Children
        LIU Kefeng,YANG Yongjie,ZHANG Xiaojian,KANG Jian(Dept. of Pharmacy,the First Affiliated Hospital of
        Zhengzhou University,Zhengzhou 450052,China)

        ABSTRACT OBJECTIVE:To systematically evaluate the efficacy and safety of intranasal administration of dexmedetomidine versus
        oral administration of chloral hydrate for programmed sedation in children. METHODS:Retrieved from Cochrane Library,PubMed,
        Embase,CBM,CNKI and Wanfang database,randomized controlled trials(RCTs)about intranasal administration of dexmedetomidine
        (trial group) versus oral administration of chloral hydrate (control group) for programmed sedation in children were collected.
        Cochrane 5.1.0 bias risk assessment tool was used to evaluate the quality of the included literatures after literature screening and data
        extraction,and Meta-analysis was conducted by using Rev Man 5.3 statistical software. RESULTS:A total of 8 RCTs were included,
        with a total of 1 413 children. Meta-analysis showed that the sedation success rate [RR=1.13,95%CI(1.02,1.25),P=0.02],sedation
        onset time [MD=-1.07,95%CI(-1.82,-0.31),P=0.006],sedation duration [MD=-8.25,95%CI(-14.02,-2.47),P=
        0.005],wake-up time [MD=-9.63,95%CI(-15.40,-3.86),P=0.001],the incidence of nausea and vomiting [RR=0.05,95%CI
        (0.02,0.14),P<0.000 01] in the trial group were significantly better than those in control group. There was no statistical significance
        in the incidence of SpO2<95% [RR=0.60,95%CI(0.24,1.54),P=0.29],incidence of hypotension [RR=1.18,95%CI(0.51,

        

             动学的影响[J].临床研究,2017,38(5):358-360.              [31]  杨燕,辛华雯,刘飞,等.五酯胶囊对他克莫司增效作用与
        [30]  FU SX,WANG LM,ZHU YH. Effect of Wuzhi capsule      CYP3A5*3 基因多态性的相关性研究[J].中国药房,
             on blood concentration of tacrolimus in renal graft recipi-  2017,28(5):581-584.
             ents[J]. Pharm Care Res,2009,9(4):275-278.     [32]  LUNDE I,BREMER S,MIDTVEDT K,et al. The influ-
                                                                 ence of CYP3A,PPARA,and POR genetic variants on the
            Δ 基 金 项 目 :国 家 重 点 研 发 计 划 精 准 医 学 研 究 重 点 专 项
                                                                 pharmacokinetics of tacrolimus and cyclosporine in renal
        (No.2017YFC0909900)
                                                                 transplant recipients[J]. Eur J Clin Pharmacol,2014,70
            *主管药师,硕士。研究方向:临床药理学、循证医学。电话:
                                                                (6):685-693.
        0371-66862018。E-mail:liukefeng-num.1@163.com
                                                                         (收稿日期:2019-06-19 修回日期:2019-11-28)
            # 通信作者:副主任药师,硕士。研究方向:药事管理、循证医
                                                                                                 (编辑:张元媛)
        学。电话:0371-66913047。E-mail:2455232597@qq.com
        ·484  ·  China Pharmacy 2020 Vol. 31 No. 4                                   中国药房    2020年第31卷第4期
   105   106   107   108   109   110   111   112   113   114   115